Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;25(5):445-454.
doi: 10.1007/s11912-023-01375-8. Epub 2023 Mar 3.

Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment

Affiliations
Review

Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment

Suparna C Clasen et al. Curr Oncol Rep. 2023 May.

Abstract

Purpose of review: Testicular cancer (TC) is the leading cancer in men between 18 and 39 years of age. Current treatment involves tumor resection followed by surveillance and/or one or more lines of cisplatin-based chemotherapy (CBCT) and/or bone marrow transplant (BMT). Ten years after treatment, CBCT has been associated with significant atherosclerotic cardiovascular disease (CVD) including myocardial infarction (MI), stroke, and heightened rates of hypertension, dyslipidemia, diabetes mellitus, and metabolic syndrome (MetS). Additionally, low testosterone levels and hypogonadism contribute to MetS and may further drive CVD.

Recent findings: CVD in TCS has been associated with worse physical functioning accompanied by role limitations, decreased energy, and decreased overall health. Exercise may play a role in ameliorating these effects. Systematic CVD screening practices are needed at TC diagnosis and in survivorship. We encourage a multidisciplinary partnership between primary care physicians, cardiologists, cardio-oncologists, medical oncologists, and survivorship providers to address these needs.

Keywords: Cardiovascular disease; Hypertension; Platinum; Prevention; Survivorship; Testicular cancer.

PubMed Disclaimer

Similar articles

Cited by

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Testicular Cancer: Statistics, in Board CNE (ed): Testicular cancer guide, 2005–2022 American Society of Clinical Oncology (ASCO), 02/2022. https://www.cancer.net/cancer-types/testicular-cancer/statistics
    1. Trama A, Foschi R, Larrañaga N, et al. Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2206–16. - PubMed - DOI
    1. Einhorn LH, Williams SD, Chamness A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med. 2007;357:340–8. - PubMed - DOI
    1. Fung C, Fossa SD, Milano MT, et al. Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol. 2015;33:3105–15. - PubMed - PMC - DOI
    1. •• Lauritsen J, Hansen MK, Bandak M, Kreiberg MB, Skøtt JW, Wagner T, Gundgaard Kier MG, Holm NV, Agerbæk M, Gupta R, Dehlendorff C, Andersen KK, Daugaard G. Cardiovascular Risk Factors and Disease After Male Germ Cell Cancer. J Clin Oncol. 2020;38(6):584-592. https://doi.org/10.1200/JCO.19.01180 . This well-designed thoughtful national cohort study has defined the prevalence of both cardiovascular risk factors and cardiovascular disease in testicular cancer survivorship.

MeSH terms

Supplementary concepts

LinkOut - more resources